The Role of Esketamine in the Treatment of TRD

Video

Merrideth Leggat, MD, reviews clinical and practical implications of findings from the TRANSFORM and SUSTAIN studies exploring the utility of esketamine in the treatment of TRD.

Recent Videos
Geoffrey Grammer, MD, presenting slides
Robert Zalewski-Zaragoza, MD, presenting slides
William Sauve, MD, presenting slides
Harman Deol, MD, presenting slides
Casey Paleos, MD | Credit: LinkedIn
Casey Paleos, MD | Credit: LinkedIn
Casey Paleos, MD | Credit: LinkedIn
Casey Paleos, MD | Credit: LinkedIn
Related Content
The 5-Fold Psychosis, Mania Risk on High Dose Amphetamine with Lauren Moran, MD

The 5-Fold Psychosis, Mania Risk on High Dose Amphetamine with Lauren Moran, MD

Chelsie Derman
September 12th 2024
Article
The Physician Burnout Crisis, with Sue Padernacht, EDd, PCC

The Physician Burnout Crisis, with Sue Padernacht, EDd, PCC

Kevin Kunzmann
January 11th 2024
Podcast
Mirtazapine Fails to Ease Breathlessness in New Study Despite Previous Hopes

Mirtazapine Fails to Ease Breathlessness in New Study Despite Previous Hopes

Chelsie Derman
September 10th 2024
Article
John J. Miller, MD: A New Era For Psychiatric Medications

John J. Miller, MD: A New Era For Psychiatric Medications

Kenny Walter
August 18th 2022
Podcast
Psychiatry Month in Review: August 2024

Psychiatry Month in Review: August 2024

Chelsie Derman
September 4th 2024
Article
Phase 2 Data Supports the Effectiveness, Safety of NBI-1117568 for Schizophrenia

Phase 2 Data Supports the Effectiveness, Safety of NBI-1117568 for Schizophrenia

Chelsie Derman
August 28th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.